Study of Milnacipran for the Treatment of Fibromyalgia
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00314249. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Pivotal, Multicenter, Double-blind, Randomized, Placebo-Controlled Monotherapy Study of Milnacipran for the Treatment of Fibromyalgia.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to demonstrate the efficacy and safety of milnacipran at a dosage of 100 mg/day in the treatment of the fibromyalgia syndrome or the pain associate with fibromyalgia.
Study identification
- NCT ID
- NCT00314249
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,025 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2006 (Type not available)
- Primary completion
- Jun 2008 (Actual)
- Completion
- Not listed
- Last update posted
- Jan 20, 2010
Started 2006
United States locations
- U.S. sites
- 24
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site | Tuscaloosa | Alabama | 35406 | — |
| Forest Investigative Site | Fresno | California | 93710 | — |
| Forest Investigative Site | Pismo Beach | California | 93449 | — |
| Forest Investigative Site | Vista | California | 92083 | — |
| Forest Investigative Site | St. Petersburg | Florida | 33702 | — |
| Forest Investigative Site | St. Petersburg | Florida | 33709 | — |
| Forest Investigative Site | Stuart | Florida | 34996 | — |
| Forest Investigative Site | Atlanta | Georgia | 30328 | — |
| Forest Investigative Site | Springfield | Massachusetts | 01107 | — |
| Forest Investigative Site | Worcester | Massachusetts | 01610 | — |
| Forest Investigative Site | Omaha | Nebraska | 68134 | — |
| Forest Investigative Site | Haddon Heights | New Jersey | 08035 | — |
| Forest Investigative Site | Johnson City | New York | 13790 | — |
| Forest Investigative Site | Syracuse | New York | 13210 | — |
| Forest Investigative Site | Greensboro | North Carolina | 27408 | — |
| Forest Investigative Site | Cleveland | Ohio | 44122 | — |
| Forest Investigative Site | Columbus | Ohio | 43212 | — |
| Forest Investigative Site | Toledo | Ohio | 43623 | — |
| Forest Investigative Site | Eugene | Oregon | 97401 | — |
| Forest Investigative Site | Mechanicsburg | Pennsylvania | 17055 | — |
| Forest Investigative Site | Anderson | South Carolina | 29621 | — |
| Forest Investigative Site | Greer | South Carolina | 29651 | — |
| Forest Investigative Site | Richardson | Texas | 75080 | — |
| Forest Investigative Site | Virginia Beach | Virginia | 23454 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00314249, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 20, 2010 · Synced Nov 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.